Tejnaksh Healthcare Ltd - Grant Of Patent To Dr. Ashish Rawandale Patil (Managing Director) For An Invention Entitled As CRABTRITE FORCEP"

| Updated on April 01, 2019 Published on April 01, 2019

With reference to captioned subject, we are pleased to inform you that Dr. Ashish Rawandale Patil has been granted a patent by the Government of India, the patent office, for an invention entitled as Crabtrite Forcep.

Crabtrite is an instrument which would enable the surgeon to hold a stone with a prong like instrument and break the stone through a central cavity provided at the center of the instrument using laser or pneumatic energy.

This innovation prevents migration of stones during breaking which is a major advantage. It also allows for retrieval of stones and use with any energy source desired.

The said patent right allows us to solely manufacture and sell the unit. The Manufacturing of the same would be commencing shortly.

The above mentioned patent is valid for a term of 20 years commencing from the 12th Day of January, 2011.

This is for your intimation and record.

Pdf Link: Tejnaksh Healthcare Ltd - Grant Of Patent To Dr. Ashish Rawandale Patil (Managing Director) For An Invention Entitled As CRABTRITE FORCEP"

Source : BSE - www.bseindia.com

Published on April 01, 2019

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.